Hildegard Büning

Hildegard Büning is Professor of Infection Biology and Gene Transfer and Deputy Director of the Institute of Experimental Hematology at Hannover Medical School (Germany). She served as President of the European Society of Gene and Cell Therapy (www.ESGCT.eu, 2018-2022), as Member of the Board of Directors of the American Society of Gene & Cell Therapy (https://asgct.org/;2021-2024) and is the Scientific Secretary of the German Society for Gene Therapy (www.dg-gt.de/; since 2014). She studied Biology and obtained her PhD (Dr. rer. nat.) at the Ludwig-Maximilians-University Munich (Germany) in 1997. Since then, she is active in the field of adeno-associated virus (AAV) vectors with a particular focus on AAV-host interactions and vector development. Aiming to improve efficacy and safety of AAV vectors for gene therapy, she is tailoring vector tropism and immunogenicity using both rational design and library-based approaches.